학술논문
Authors' reply to the comment “High-dose, high-frequency infliximab: A novel treatment paradigm for hidradenitis suppurativa”
Document Type
Correspondence
Author
Source
In Journal of the American Academy of Dermatology April 2021 84(4):e203-e204
Subject
Language
ISSN
0190-9622